Edurant 25 mg

Edurant 25 mg tablets contain rilpivirine hydrochloride, an antiretroviral medication used to manage HIV-1 infection. This prescription-only treatment is taken orally and is part of combination therapy for HIV.

Edurant 25 mg tablets are primarily used in the treatment of HIV-1 infection in adults. Rilpivirine, the active ingredient, works by inhibiting the virus's ability to replicate. This medication is typically prescribed as part of a broader antiretroviral therapy regimen to help manage HIV. What is Edurant used for? It is used to reduce the amount of HIV in the body, improving immune function and decreasing the risk of HIV-related complications.

Common effects of Edurant 25 mg tablets may include headache, dizziness, nausea, and rash. Some individuals might experience changes in body fat distribution or depression. These effects vary among users and are not experienced by everyone. If any symptoms persist or worsen, it is important to consult a healthcare provider.

Edurant 25 mg tablets should be handled with care. Store the medication at room temperature, away from moisture and heat. Do not crush or chew the tablets; swallow them whole with a full glass of water. This medication should be taken consistently as prescribed, and any missed doses should be taken as soon as possible, unless it is almost time for the next dose.

Edurant 25 mg tablets can interact with other medications, including antacids, proton pump inhibitors, and certain antifungal or antibiotic drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy of the medication.